Wellington Management Group LLP Sells 22,925 Shares of Liquidia Corporation $LQDA

Wellington Management Group LLP lessened its holdings in Liquidia Corporation (NASDAQ:LQDA) by 11.5% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 176,135 shares of the company’s stock after selling 22,925 shares during the period. Wellington Management Group LLP owned 0.20% of Liquidia worth $14,043,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Covestor Ltd raised its position in shares of Liquidia by 41.9% during the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after buying an additional 359 shares in the last quarter. PNC Financial Services Group Inc. grew its position in Liquidia by 7.2% in the fourth quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock worth $217,000 after acquiring an additional 422 shares in the last quarter. Quantinno Capital Management LP increased its stake in Liquidia by 3.6% in the first quarter. Quantinno Capital Management LP now owns 17,165 shares of the company’s stock valued at $648,000 after acquiring an additional 589 shares during the last quarter. Northwestern Mutual Wealth Management Co. bought a new position in Liquidia in the fourth quarter valued at $25,000. Finally, ProShare Advisors LLC raised its position in Liquidia by 7.1% during the fourth quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock valued at $405,000 after purchasing an additional 775 shares in the last quarter. 64.54% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Liquidia

In other Liquidia news, CAO Dana Boyle sold 1,600 shares of the firm’s stock in a transaction on Monday, July 27th. The shares were sold at an average price of $87.53, for a total value of $140,048.00. Following the sale, the chief accounting officer owned 167,919 shares of the company’s stock, valued at $14,697,950.07. This trade represents a 0.94% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Katherine Rielly-Gauvin sold 18,393 shares of the business’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $72.23, for a total transaction of $1,328,526.39. Following the completion of the transaction, the director owned 44,637 shares in the company, valued at $3,224,130.51. The trade was a 29.18% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,314,241 shares of company stock worth $96,868,670 over the last ninety days. 25.60% of the stock is owned by company insiders.

Liquidia Price Performance

LQDA opened at $68.66 on Tuesday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.31 and a quick ratio of 2.12. The stock’s 50 day simple moving average is $78.38 and its 200 day simple moving average is $58.50. The firm has a market cap of $6.15 billion, a price-to-earnings ratio of 50.12 and a beta of 0.53. Liquidia Corporation has a 1 year low of $21.15 and a 1 year high of $93.61.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings data on Wednesday, August 12th. The company reported $0.74 earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The company had revenue of $171.68 million for the quarter, compared to analysts’ expectations of $168.48 million. During the same period last year, the company posted ($0.49) EPS. The business’s revenue for the quarter was up 1842.1% compared to the same quarter last year. As a group, analysts predict that Liquidia Corporation will post 2.57 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on LQDA. Needham & Company LLC upped their price objective on Liquidia from $70.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, August 12th. Jefferies Financial Group restated a “buy” rating and issued a $60.00 target price on shares of Liquidia in a research report on Monday, May 11th. Piper Sandler set a $129.00 price target on shares of Liquidia in a research report on Friday, July 24th. HC Wainwright set a $36.00 price target on shares of Liquidia in a research note on Friday, July 24th. Finally, Royal Bank Of Canada set a $130.00 price objective on shares of Liquidia in a research note on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $98.08.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).